This article summarizes the eight major randomized, controlled clinical trials of breast cancer screening with mammography, provides an objective critical review of the evidence for screening, and assesses the current state of knowledge about breast cancer screening. This report concludes that, for women between 50 and 69 years of age, screening significantly reduces mortality from breast cancer by approximately 30%. For women under 50 and over 69 years of age, trial data do not provide adequate information to judge effectiveness. (See also "Deficiencies in the analysis of breast cancer screening data," a dissention from the main conclusions, in the same issue.) This metaanalysis combines the results of 13 controlled studies, both randomized and casecontrol varieties, and concludes that screening mammography significantly reduces the mortality from breast cancer in women between 50 and 74 years of age. Screening may be effective in women between 40 and 49 years of age after 10 to 12 years, but the same benefit might be achieved by beginning screening at age 50.
